FK 3311

Known as: FK-3311, FK3311 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2009
01219932009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
PURPOSE Our objective was to evaluate whether COX-2 inhibition with FK3311, a selective cyclooxygenase (COX)-2 inhibitor… (More)
Is this relevant?
2007
2007
BACKGROUND/AIMS This study was designed to investigate the effects of a selective cyclooxygenase-2 inhibitor, FK3311, on warm… (More)
Is this relevant?
2007
2007
Ischemia-reperfusion injury is induced by activation of the arachidonic acid cascade following the induction of cyclooxygenase-2… (More)
Is this relevant?
2006
2006
BACKGROUND Cyclooxygenase (COX) is an intracellular enzyme that converts arachidonic acid to prostaglandin endoperoxide (PGG(2… (More)
Is this relevant?
2003
2003
BACKGROUND/AIMS The purpose of this study was to investigate the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia… (More)
Is this relevant?
2001
2001
BACKGROUND This study investigated the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia-reperfusion (I/R) injury… (More)
Is this relevant?
2001
2001
BACKGROUND Liver grafts from non-heart-beating donors inevitably suffer from warm ischemic injury. In these grafts, large… (More)
Is this relevant?
2001
2001
BACKGROUND In the process of ischemia-reperfusion, inflammatory cytokines and arachidonic acid metabolites are released and… (More)
Is this relevant?
2001
2001
BACKGROUND Pringle's procedure is commonly used during liver surgery, and it sometimes causes liver failure. Metabolites of… (More)
Is this relevant?
2000
2000
T614 (3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne) is a member of the family of methanesulfonanilide non… (More)
Is this relevant?